Thermo Fisher Scientific Prices Offering of Common Stock

WALTHAM, Mass., Aug. 8, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has priced its underwritten public offering of 8,771,930 shares of common stock at a price of $171.00 per share for expected gross proceeds of approximately $1.5 billion, before the underwriting discount and expenses. Thermo Fisherhas also granted the underwriters a 30-day option to purchase up to... Read more

Shimadzu Releases LC/MS/MS Sample Prep Kit for Quantitative Analysis of Monoclonal Antibodies

August 7 2017 Shimadzu Scientific Instruments (SSI) announces the release of the nSMOL (nano-surface and molecular orientation limited proteolysis) Antibody Bio-Analysis Kit. Applicable to a variety of pharmaceutical antibodies, this proprietary technique enables selective proteolysis of the Fab region of monoclonal antibodies to dramatically improve the productivity and robustness of LCMS mAB bioanalysis. The nSMOL... Read more

Bruker Introduces Software Package for Layer Analysis with XTrace Micro-XRF on Electron Microscopes

ST. LOUIS, Missouri – August 7, 2017 – At the Microscopy & Microanalysis 2017 Meeting Bruker today presents XMethod, the world’s first software package for the analysis of composition and thickness of single or multiple layers, based on data obtained by sample excitation with the XTrace micro-focus X-ray source for scanning electron microscopes (SEM). The software enables... Read more

Thermo Fisher Scientific Advances Cryo-EM Leadership to Drive Structural Biology Discoveries

New Thermo Scientific Krios G3i raises bar for performance, automation and time-to-results Breakthrough Thermo Scientific Glacios provides a cryo-EM entry path for a broader range of researchers ST. LOUIS, Aug. 7, 2017 /PRNewswire/ — Microscopy & Microanalysis 2017 — Thermo Fisher Scientific, the world leader in serving science, has extended its leadership in cryo-electron microscopy (cryo-EM) with the introduction of... Read more

Industry’s First Dedicated Cryo-DualBeam System Automates Preparation of Frozen, Biological Samples

New Thermo Scientific Aquilos FIB/SEM protects sample integrity and enhances productivity for cryo-electron tomography workflow ST. LOUIS, Aug. 7, 2017 /PRNewswire/ — Microscopy & Microanalysis 2017 – The new Thermo Scientific Aquilos is the first commercial cryo-DualBeam (focused ion beam/scanning electron microscope) system dedicated to the preparation of frozen, thin lamella samples from biological specimens for high-resolution tomographic imaging in a... Read more

New Quattro Field Emission ESEM Emphasizes Versatility and Ease of Use

Thermo Scientific Quattro ESEM allows materials science researchers to study nanoscale structure in almost any material under a range of environmental conditions ST. LOUIS, Aug. 7, 2017 /PRNewswire/ — Microscopy & Microanalysis 2017 — The ability of scientists to study samples at the nanometer scale and in natural conditions and environments is critical to the discovery and development of... Read more

Thermo Fisher Extends Cash Tender Offer for All Outstanding Shares of Patheon to Coordinate Offer Timing with Two Remaining Regulatory Approvals

Offer Now Scheduled to Expire at 5:00 p.m., New York City Time, on August 28, 2017 WALTHAM, Mass., Aug. 7, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg S.à r.l., has extended the offering period of its previously announced all-cash tender offer to... Read more

Thermo Fisher Scientific Announces $1.5 Billion Offering of Common Stock

WALTHAM, Mass., Aug. 7, 2017 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it has commenced an underwritten public offering of $1.5 billion of its common stock. Thermo Fisher also intends to grant the underwriters an option for a period of 30 days to purchase up to $225.0 million of additional shares of its common stock. All of the shares in the... Read more

FDA Issues Emergency Use Authorization for Thermo Fisher Scientific’s Zika Virus Assay

CARLSBAD, Calif., Aug. 3, 2017 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization for the company’s new TaqPath Zika Virus Kit. The TaqPath Zika Virus Kit is authorized only for the qualitative detection of RNA from Zika virus and... Read more